Jiangsu Hengrui Pharmaceuticals Co Ltd Class A 600276
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 600276 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CNY 45.53
- Day Range
- CNY 45.22–45.78
- 52-Week Range
- CNY 35.51–50.50
- Bid/Ask
- CNY 45.33 / CNY 45.34
- Market Cap
- CNY 289.16 Bil
- Volume/Avg
- 19.7 Mil / 27.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 62.64
- Price/Sales
- 12.35
- Dividend Yield (Trailing)
- 0.35%
- Dividend Yield (Forward)
- 0.35%
- Total Yield
- 0.35%
Company Profile
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Growth
- Total Number of Employees
- 19,611
- Website
- http://www.hrs.com.cn
Comparables
Valuation
Metric
|
600276
|
600594
|
300194
|
---|---|---|---|
Price/Earnings (Normalized) | 62.64 | — | 17.38 |
Price/Book Value | 6.94 | 1.08 | 1.19 |
Price/Sales | 12.35 | 1.20 | 1.89 |
Price/Cash Flow | 33.17 | 7.81 | 9.49 |
Price/Earnings
600276
600594
300194
Financial Strength
Metric
|
600276
|
600594
|
300194
|
---|---|---|---|
Quick Ratio | — | 1.25 | 1.18 |
Current Ratio | — | 1.90 | 1.77 |
Interest Coverage | — | 1.12 | 10.96 |
Quick Ratio
600276
600594
300194
Profitability
Metric
|
600276
|
600594
|
300194
|
---|---|---|---|
Return on Assets (Normalized) | 10.04% | −0.72% | 0.94% |
Return on Equity (Normalized) | 10.92% | −1.13% | 1.40% |
Return on Invested Capital (Normalized) | 9.87% | −0.39% | 1.12% |
Return on Assets
600276
600594
300194
Drug Manufacturers - General Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Llbmrswm | Bwcw | $720.1 Bil | |
JNJ
| Johnson & Johnson | Zrqyygk | Yrr | $363.9 Bil | |
MRK
| Merck & Co Inc | Ghktxbqrs | Yrl | $327.5 Bil | |
ABBV
| AbbVie Inc | Pmpvvghk | Cygrm | $284.8 Bil | |
AZN
| AstraZeneca PLC ADR | Cgwmmgxtfv | Ffwp | $240.2 Bil | |
NVS
| Novartis AG ADR | Kvdfhjd | Hrft | $209.5 Bil | |
RHHBY
| Roche Holding AG ADR | Gkvjscshmw | Xcw | $202.8 Bil | |
AMGN
| Amgen Inc | Xzgcnlgrv | Zyghd | $165.5 Bil | |
PFE
| Pfizer Inc | Bmfvxgm | Zsk | $161.2 Bil | |
SNY
| Sanofi SA ADR | Bbcyzdqk | Wpks | $127.1 Bil |